Non-clinical combination toxicology studies: strategy, examples and future perspective
The Journal of Toxicological Sciences · 2020 · 45 (7) · 365-371
DOI: 10.2131/jts.45.365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Toxicological Sciences, 2020. Verfasst von Aida Sacaan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Drug Safety Research and Development, Pfizer, Inc., USA. Hauptthemen laut MEDLINE: Drug Development. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Safety Research and Development, Pfizer, Inc., USA.
- Drug Safety Research and Development, Pfizer R&D Japan G.K., Japan.
Zitieren
APA
Sacaan, A., Hashida, S. N., & Khan, N. K. (2020). Non-clinical combination toxicology studies: strategy, examples and future perspective. The Journal of Toxicological Sciences, 45(7), 365-371. https://doi.org/10.2131/jts.45.365
Vancouver
Sacaan A, Hashida SN, Khan NK. Non-clinical combination toxicology studies: strategy, examples and future perspective. The Journal of Toxicological Sciences. 2020;45(7):365-371. doi:10.2131/jts.45.365
BibTeX
@article{Sacaan2020,
author = {Sacaan, Aida and Hashida, Satoko Nonaka and Khan, Nasir K},
title = {Non-clinical combination toxicology studies: strategy, examples and future perspective},
journal = {The Journal of Toxicological Sciences},
year = {2020},
volume = {45},
number = {7},
pages = {365--371},
doi = {10.2131/jts.45.365}
}
EUVIMED